Drostanolone enanthate is an anabolic steroid that belongs to the class of androgenic hormones. It is a synthetic derivative of dihydrotestosterone (DHT) and has potent anticancer activity against prostate carcinoma cells. Drostanolone enanthate inhibits the growth of cancer cells by binding to the androgen receptor, which is located in the cytoplasm. This causes a conformational change in the receptor that prevents it from interacting with DNA. Drostanolone enanthate also inhibits fatty acid synthesis and microbial biotransformation, which may have anticancer effects.